Pharmacotherapies and Aortic Heme Oxygenase-1 Expression in Patients with Abdominal Aortic Aneurysm
Authors:
- Anja HofmannAHAnja Hofmann
- Bianca HamannBHBianca Hamann
- Anna KlimovaAKAnna Klimova
- Margarete MüglichMMMargarete Müglich
- Steffen WolkSWSteffen Wolk
- Albert BuschABAlbert Busch
- Frieda FrankFFFrieda Frank
- Pamela SabarstinskiPSPamela Sabarstinski
- Marvin KapallaMKMarvin Kapalla
- Josef Albin NeesJNJosef Albin Nees
- Coy BrunssenCBCoy Brunssen
- David M. PoitzDPDavid M. Poitz
Open Access
- 4 September 2022
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (9) , 1753
Abstract
Background: Treatment of cardiovascular risk factors slows the progression of small abdominal aortic aneurysms (AAA). Heme oxygenase-1 (HO-1) is a stress- and hemin-induced enzyme providing cytoprotection against oxidative stress when overexpressed. However, nothing is known about the effects of cardiometabolic standard therapies on HO-1 expression in aortic walls in patients with end-stage AAA. Methods: The effects of statins, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers (CCBs), beta-blockers, diuretics, acetylsalicylic acid (ASA), and therapeutic anticoagulation on HO-1 mRNA and protein expressions were analyzed in AAA patients using multivariate logistic regression analysis and comparison of monotherapy. Results: Analysis of monotherapy revealed that HO-1 mRNA and protein expressions were higher in patients on diuretics and lower in patients on statin therapy. Tests on combinations of antihypertensive medications demonstrated that ACE inhibitors and diuretics, ARBs and diuretics, and beta-blockers and diuretics were associated with increase in HO-1 mRNA expression. ASA and therapeutic anticoagulation were not linked to HO-1 expression. Conclusion: Diuretics showed the strongest association with HO-1 expression, persisting even in combination with other antihypertensive medications. Hence, changes in aortic HO-1 expression in response to different medical therapies and their effects on vessel wall degeneration should be analyzed in future studies.Keywords
Funding Information
- MeDDrive program 2019 of the Medical Faculty of TU Dresden (MO 1695/5-1, IRTG 2251, 3-2, F03661-553-41B-1250000)
- Carus Promotionskolleg fellowship of the Medical Faculty of TU Dresden (MO 1695/5-1, IRTG 2251, 3-2, F03661-553-41B-1250000)
- Deutsche Forschungsgemeinschaft (DFG) (MO 1695/5-1, IRTG 2251, 3-2, F03661-553-41B-1250000)
- Excellence Initiative of the German Federal State Governments (MO 1695/5-1, IRTG 2251, 3-2, F03661-553-41B-1250000)
This publication has 37 references indexed in Scilit:
- Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrityJournal of Vascular Surgery, 2013
- Plasma and Urinary Heme Oxygenase-1 in AKIJournal of the American Society of Nephrology, 2012
- A Central Role of Heme Oxygenase-1 in Cardiovascular ProtectionAntioxidants & Redox Signaling, 2011
- Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diureticsExpert Review of Cardiovascular Therapy, 2010
- Pharmacological treatment of abdominal aortic aneurysmCardiovascular Research, 2009
- Heme Oxygenase-1 Deficiency Accelerates Formation of Arterial Thrombosis Through Oxidative Damage to the Endothelium, Which Is Rescued by Inhaled Carbon MonoxideCirculation Research, 2007
- Endothelial Protection, AT 1 Blockade and Cholesterol-Dependent Oxidative StressCirculation, 2006
- Increase in heme oxygenase-1 levels ameliorates renovascular hypertensionKidney International, 2005
- Simvastatin Induces Heme Oxygenase-1Circulation, 2004
- Heme Oxygenase-1 Is Regulated by Angiotensin II in Rat Vascular Smooth Muscle CellsHypertension, 1997